4. Purpose and findings

• Parkinsons disease is a major, ongoing health challenge with significant patient, caregiver, and cost burdens.
• The bill seeks to accelerate innovation in Parkinsons research and provide support for caregivers, by creating a dedicated funding stream and governance to oversee research and related activities.
• It aims to attract researchers, strengthen Minnesota’s research status, and foster collaboration among universities, medical centers, and other grant recipients.

4. Establishment of the fund

• Creates the Minnesota Parkinsons Research Trust Fund in the state treasury as a special revenue fund (not the general fund).
• Money in the fund is held in trust and may be spent only for the purposes in this section.

4. Purposes

• Create and speed up innovation in Parkinsons disease and related disorders research.
• Improve health outcomes for Minnesota residents and increase the chances of medical breakthroughs.
• Enhance Minnesota’s research standing and attract scientific talent and jobs.
• Develop and implement a research plan that promotes collaboration among eligible higher education institutions, partners, and other grant recipients.

4. Powers and duties

• The commissioner of health may award grants to Minnesota-based institutions, research facilities, and other entities involved in Parkinsons research, including translational and clinical research into causes, prevention, treatment, rehabilitation, and therapies.
• Grants may cover research activities, facilities, equipment, salaries, and related costs; include prevention programs and strategies.
• The commissioner must collaborate with state agencies and relevant groups to maximize health care and research impact, set standards, oversee grant use, and manage staff, contracts, and compliance.
• The commissioner shall monitor grant proposals for conflicts of interest and coordinate with a statewide registry for related research.

4. Administration and oversight

• Establishes a Neurodegenerative Disease Advisory Council to oversee the fund’s administration.
• Council composition includes leading Minnesota research institutions, Parkinsons advocacy groups, caregiver support groups, and medical professionals specializing in neurological diseases.
• The council sets guidelines for grant applications, selection criteria, and reporting to ensure transparency and accountability.

4. Reporting and accountability

• Grant recipients must submit annual reports detailing research progress, caregiver support outcomes, and recommendations to improve programs.
• The commissioner must produce an annual report by January 31 to legislative chairs and ranking minority members, including:
  • List and amounts of grants awarded, research accomplishments, and progress of grant recipients.
  • Strategic research plans, estimated statewide costs of Parkinsons and related disorders (including Medicaid and retirement systems), and grants compliance program activities.
  • A publication-ready summary on the fund’s grants and impacts.

4. State plan to address neurodegenerative diseases

• Within 12 months of the act’s effective date, the commissioner (with input from the advisory council and stakeholders) must publish a state plan addressing neurodegenerative diseases.
• Plan components include: prevalence/incidence data, objectives across prevention, diagnosis, care, research, surveillance, workforce, and support services; strategies for early diagnosis and access to specialists; care coordination and caregiver support; workforce development; public awareness with an equity focus; data/registry integration; a prioritized research and innovation agenda; sustainable financing; evaluation metrics; and a public comment period of at least 30 days before finalization.

4. Coordination of activities

• The commissioner must coordinate activities with federal agencies, federally supported research centers, academic medical centers, and private partners to leverage resources and avoid duplication.
• May enter into memoranda of understanding to facilitate data sharing and collaborative research, as permitted by law.

4. Protections and limitations

• Participation in the data registry is voluntary; no one is denied services for choosing not to enroll.
• Data collected may only be used for research purposes and not for nonresearch law enforcement or discriminatory uses.
• The act does not require additional insurance coverage beyond existing state/federal requirements.

4. Rulemaking and severability

• The commissioner may adopt rules to implement the act.
• If any part is held invalid, the remainder remains in effect.

Relevant terms section follows.

Relevant Terms - Minnesota Parkinsons Research Trust Fund - special revenue fund - Parksinsons disease - neurodegenerative diseases - translational research - clinical research - research plan - grants / grant administration - investigator grants - caregiver support - Neurodegenerative Disease Advisory Council - data registry / research registry - data sharing / memoranda of understanding - conflicts of interest - reporting requirements - annual report - state plan - prevention, diagnosis, treatment, rehabilitation - workforce development - public comment - transparency / accountability - compliance / oversight - Medicaid / Teacher Retirement System / Employees Retirement System (cost reporting)